Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yichen Zhu

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Cell Reports. Medicine|August 30, 2025
Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cellsYan-Ruide Li, Junhui Hu, Zhe Li, et al.
Nature Biomedical Engineering|October 25, 2024
Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapiesZeyang Liu, Yan-Ruide Li, Youcheng Yang, et al.
Nature Biomedical Engineering|April 15, 2025
Author Correction: Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapiesZeyang Liu, Yan-Ruide Li, Youcheng Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2024
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Nature Biotechnology|May 14, 2024
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture methodYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Med (New York, N.Y.)|August 13, 2025
Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cellsYan-Ruide Li, Zhe Li, Yichen Zhu, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Cell Reports. Medicine|August 30, 2025
Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cellsYan-Ruide Li, Junhui Hu, Zhe Li, et al.
Nature Biomedical Engineering|October 25, 2024
Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapiesZeyang Liu, Yan-Ruide Li, Youcheng Yang, et al.
Nature Biomedical Engineering|April 15, 2025
Author Correction: Viscoelastic synthetic antigen-presenting cells for augmenting the potency of cancer therapiesZeyang Liu, Yan-Ruide Li, Youcheng Yang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2024
Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Nature Biotechnology|May 14, 2024
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture methodYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.
Med (New York, N.Y.)|August 13, 2025
Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cellsYan-Ruide Li, Zhe Li, Yichen Zhu, et al.
Pageof 12